Kaposi sarcoma
Disease1 paper
- In silico1
Trial sponsors
Company4 trialsPhase 3445 people
Company1 trialPhase 3
National Institute of Allergy and Infectious Diseases
5 trialsPhase 2300 people
Institut National de la Santé Et de la Recherche Médicale, France
1 trialPhase 211 people
Latest
1Journal of the College of Physicians and Surgeons--PakistanIn silico